Overall survival with momelotinib vs. best available therapy in patients with ruxolitinib-experienced myelofibrosis: a matching-adjusted indirect comparison.
Saved in:
| Title: | Overall survival with momelotinib vs. best available therapy in patients with ruxolitinib-experienced myelofibrosis: a matching-adjusted indirect comparison. |
|---|---|
| Authors: | Palandri F; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy. francesca.palandri@unibo.it., Kapetanakis V; Evidera, London, UK., Dobi B; Evidera, Budapest, Hungary., Breccia M; Department of Translational and Precision Medicine, Azienda Policlinico Umberto I, Sapienza University, Roma, Italy., Palumbo GA; Department of Scienze Mediche, Chirurgiche e Tecnologie Avanzate 'G.F. Ingrassia', University of Catania, Catania, Italy., Abruzzese E; S Eugenio Hospital, ASL Roma 2, Tor Vergata University, Roma, Italy., Bonifacio M; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, University of Verona, Verona, Italy., Tiribelli M; Division of Hematology and BMT, ASUFC and Department of Medicine, University of Udine, Udine, Italy., Elli EM; Hematology Division and Bone Marrow Unit, Fondazione IRCCS, San Gerardo dei Tintori, Monza, Italy., Morsia E; Hematology Unit, Department of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy., Branzanti F; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy., Ellis CE; GSK plc, Collegeville, PA, USA., Ballew N; GSK plc, Collegeville, PA, USA., Liu T; GSK plc, Collegeville, PA, USA., Phiri K; GSK plc, Collegeville, PA, USA., Sen Nikitas F; GSK plc, London, UK., Zhang S; GSK plc, Collegeville, PA, USA., Patnaik D; GSK plc, Baar, Switzerland. |
| Source: | Annals of hematology [Ann Hematol] 2026 Feb 21; Vol. 105 (4). Date of Electronic Publication: 2026 Feb 21. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41721879 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Overall survival with momelotinib vs. best available therapy in patients with ruxolitinib-experienced myelofibrosis: a matching-adjusted indirect comparison. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Palandri+F%22">Palandri F</searchLink>; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy. francesca.palandri@unibo.it.<br /><searchLink fieldCode="AU" term="%22Kapetanakis+V%22">Kapetanakis V</searchLink>; Evidera, London, UK.<br /><searchLink fieldCode="AU" term="%22Dobi+B%22">Dobi B</searchLink>; Evidera, Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Breccia+M%22">Breccia M</searchLink>; Department of Translational and Precision Medicine, Azienda Policlinico Umberto I, Sapienza University, Roma, Italy.<br /><searchLink fieldCode="AU" term="%22Palumbo+GA%22">Palumbo GA</searchLink>; Department of Scienze Mediche, Chirurgiche e Tecnologie Avanzate 'G.F. Ingrassia', University of Catania, Catania, Italy.<br /><searchLink fieldCode="AU" term="%22Abruzzese+E%22">Abruzzese E</searchLink>; S Eugenio Hospital, ASL Roma 2, Tor Vergata University, Roma, Italy.<br /><searchLink fieldCode="AU" term="%22Bonifacio+M%22">Bonifacio M</searchLink>; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, University of Verona, Verona, Italy.<br /><searchLink fieldCode="AU" term="%22Tiribelli+M%22">Tiribelli M</searchLink>; Division of Hematology and BMT, ASUFC and Department of Medicine, University of Udine, Udine, Italy.<br /><searchLink fieldCode="AU" term="%22Elli+EM%22">Elli EM</searchLink>; Hematology Division and Bone Marrow Unit, Fondazione IRCCS, San Gerardo dei Tintori, Monza, Italy.<br /><searchLink fieldCode="AU" term="%22Morsia+E%22">Morsia E</searchLink>; Hematology Unit, Department of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy.<br /><searchLink fieldCode="AU" term="%22Branzanti+F%22">Branzanti F</searchLink>; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Ellis+CE%22">Ellis CE</searchLink>; GSK plc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Ballew+N%22">Ballew N</searchLink>; GSK plc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Liu+T%22">Liu T</searchLink>; GSK plc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Phiri+K%22">Phiri K</searchLink>; GSK plc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Sen+Nikitas+F%22">Sen Nikitas F</searchLink>; GSK plc, London, UK.<br /><searchLink fieldCode="AU" term="%22Zhang+S%22">Zhang S</searchLink>; GSK plc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Patnaik+D%22">Patnaik D</searchLink>; GSK plc, Baar, Switzerland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229107334%22">Annals of hematology</searchLink> [Ann Hematol] 2026 Feb 21; Vol. 105 (4). <i>Date of Electronic Publication: </i>2026 Feb 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Comparative Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9107334 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0584 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209395555%22">09395555 </searchLink><i>NLM ISO Abbreviation: </i>Ann Hematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41721879 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00277-026-06873-w Languages: – Code: eng Text: English Titles: – TitleFull: Overall survival with momelotinib vs. best available therapy in patients with ruxolitinib-experienced myelofibrosis: a matching-adjusted indirect comparison. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Palandri F – PersonEntity: Name: NameFull: Kapetanakis V – PersonEntity: Name: NameFull: Dobi B – PersonEntity: Name: NameFull: Breccia M – PersonEntity: Name: NameFull: Palumbo GA – PersonEntity: Name: NameFull: Abruzzese E – PersonEntity: Name: NameFull: Bonifacio M – PersonEntity: Name: NameFull: Tiribelli M – PersonEntity: Name: NameFull: Elli EM – PersonEntity: Name: NameFull: Morsia E – PersonEntity: Name: NameFull: Branzanti F – PersonEntity: Name: NameFull: Ellis CE – PersonEntity: Name: NameFull: Ballew N – PersonEntity: Name: NameFull: Liu T – PersonEntity: Name: NameFull: Phiri K – PersonEntity: Name: NameFull: Sen Nikitas F – PersonEntity: Name: NameFull: Zhang S – PersonEntity: Name: NameFull: Patnaik D IsPartOfRelationships: – BibEntity: Dates: – D: 21 M: 02 Text: 2026 Feb 21 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1432-0584 Numbering: – Type: volume Value: 105 – Type: issue Value: 4 Titles: – TitleFull: Annals of hematology Type: main |
| ResultId | 1 |
